NEWSROOM | Galderma

Galderma and CETAPHIL® Announce Renewed Commitment to Environmental Sustainability and Social Impact Through New Clear Skies Initiative

Galderma announces exclusive agreement with Sofregen to develop the next generation of biostimulator fillers using silk-based technology

Cetaphil® Announces Major Evolution in Brand’s Mission to Advance Sensitive Skin Science

Galderma to present new data from leading aesthetics portfolio and launch RESTYLANE® EYELIGHT™ at AMWC 2021

Sol-Gel Technologies Announces FDA Approval of TWYNEO®

Galderma receives FDA approval for Restylane® Contour for cheek augmentation and correction of midface contour deficiencies

Sol-Gel Technologies and Galderma announce exclusive licenses for the commercialization of EPSOLAY® and TWYNEO® in the United States

Alluzience®, the first ready-to-use BoNT-A neuromodulator, receives positive decision for use in Europe

How Galderma's Environmental, Social and corporate Governance approach guides its roadmap for sustainable growth

Galderma launches CETAPHIL® line for sensitive skin and a new DAYLONG® sun protection product in Switzerland

New study reveals the impact of ‘hidden acne’ on quality of life

Galderma launches new Multichannel Medical Education platform: Inaugural webinar series on the impact of mask wearing on skin diseases